The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials

Figure 6

Meta-analysis results from clinical trials for change from baseline in proptosis (a) and GO-QOL (b).

(a)

(b)